| Abstract No. |
Date |
Theme/Topic |
Topic Title |
Full Name |
Country/Region |
| APCMV1009 |
19/11/2024 |
Emerging and Zoonotic Infections |
Broadly Neutralising ACE2 Decoy as a Universal Coronavirus Therapeutic |
Matthew Zirui Tay |
Singapore |
| APCMV1268 |
19/11/2024 |
Emerging and Zoonotic Infections |
Genetic Diversity and Molecular Evolution of Hepatitis E Virus within the Genus Chirohepevirus in Bats |
Bo Wang |
Singapore |
| APCMV1286 |
19/11/2024 |
Emerging and Zoonotic Infections |
The Role of The Host Cell Microenvironment In MERS-Cov Infections |
Tessa Prince |
United Kingdom |
| APCMV1288 |
19/11/2024 |
Emerging and Zoonotic Infections |
Discovery of Porcine Deltacoronavirus in Cambodia between 2022-2024 |
Marcus Mah |
Singapore |
| APCMV1296 |
19/11/2024 |
Emerging and Zoonotic Infections |
Mitigating Risk: Validated Inactivation Methods for Safe Mpox Sample Handling |
Wei Lun Wong |
Singapore |
| APCMV1016 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Clinical Symptoms, Comorbidities and Health Outcomes Among Outpatients Infected with the Common Cold Coronaviruses Versus Influenza Virus in A Retrospective Cohort |
Kok Keng Tee |
Malaysia |
| APCMV1022 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Epidemiology and Analysis of SARS-CoV-2 Omicron Subvariants BA.1 and 2 in Taiwan |
Jih-Jin Tsai |
Taiwan |
| APCMV1038 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Impact of COVID-19 Restrictions on the Incidence of Respiratory Viruses in Two British Antarctic Survey Bases |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1066 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Time to Negative PCR Conversion Amongst COVID-19 Infected Cancer Patients at a Tertiary Care Hospital |
Gaurav Salunke |
India |
| APCMV1077 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Production and Characterisation of Recombinant Neuraminidase of Different Influenza A Virus Subtypes for Serological Analysis and Monoclonal Antibody Generation |
Kong Yen Liew |
Singapore |
| APCMV1079 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Respiratory Syncytial Virus (RSV) Epidemiology in an Adult Tertiary Healthcare Setting in Singapore |
Darius Yak Weng Chan |
Singapore |
| APCMV1081 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Neutralisation of SARS-CoV-2 Omicron Subvariant by Antibodies Targeting Stem Helix Region in S2 Subunit of the Spike Protein |
Yujia Cao |
Singapore |
| APCMV1085 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Post-COVID Influenza Trends: A Comparative Analysis of Infection Rates and Transmission Patterns Among Community Adult and Dormitory Workers in Singapore |
Benny Yeo |
Singapore |
| APCMV1090 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Adenovirus Pneumonia and Disseminated Viremia in a Neonate Successfully Treated with Cidofovir and ECMO |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1092 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Changing Patterns of Seasonal Respiratory Virus Incidence (2018-2023) Pre- and Post-COVID-19, Leicester, UK |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1136 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Mutational Characterisation of Receptor Binding Domain in The Spike Proteins of the Omicron Variants Evading Vaccine Immunity in the Northeast Indian State of Tripura |
Ankan Chakrabarti |
India |
| APCMV1190 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Development of Cellular Assays for the Comprehensive Analysis of Ferret Cytokine Responses |
V. Stalin Raj |
India |
| APCMV1200 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Characterisation of an Air-Liquid Interface Bronchial Epithelial Model for Respiratory Viral Infections |
Conrad En Zuo Chan |
Singapore |
| APCMV1245 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Impact of Viral Co-Detection on Within-Host Viral Diversity of Influenza Patients |
Su Myat Han |
Singapore |
| APCMV1256 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
The Co-Evolutionary Dynamics Between Wild-Type and Deletion-Containing Viral Genomes in Influenza Virus |
Fadi Alnaji |
Singapore |
| APCMV1289 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
The Anti-Viral Role and Therapeutic Potential of Novel Seaweed-Derived Compounds |
Daniele Mega |
United Kingdom |
| APCMV1282 |
19/11/2024 |
Influenza and Other Respiratory Viruses |
Generation of Monoclonal Antibodies Against Human Parainfluenza Virus |
Yvonne Su |
Singapore |
| APCMV1023 |
19/11/2024 |
Innovations in Vaccine Research |
Vaccination With Live-Attenuated Salmonella-Based Vaccine Expressing PCV2d Cap and Rep as a Vaccination Strategy for Mucosal and Systemic Immune Responses Against PCV2d |
John Hwa Lee |
Republic of Korea |
| APCMV1024 |
19/11/2024 |
Innovations in Vaccine Research |
Salmonella-Delivered COBRA-HA1 Antigen Derived from H1N1 Hemagglutinin Sequences Elicits Mucosal Immunity and Broad-Spectrum Protection Against Influenza A Subtypes |
John Hwa Lee |
Republic of Korea |
| APCMV1025 |
19/11/2024 |
Innovations in Vaccine Research |
Development of SFTSV Vaccine Using an RNA Replicase Augmented Multigene Expression System Compatible Via Salmonella-Mediated Gene Delivery Platform to Induce Mucosal Immune Response |
John Hwa Lee |
Republic of Korea |
| APCMV1033 |
19/11/2024 |
Innovations in Vaccine Research |
An Economical Adjuvant Without a Production Limit to Induce Potent Cell-Mediated Immunity in Subunit Vaccines |
Cunbao Liu |
China |
| APCMV1049 |
19/11/2024 |
Innovations in Vaccine Research |
Immune Response To COVID-19 mRNA Vaccines in Adolescents with Type 1 Diabetes Mellitus: A Comparative Study with Healthy Controls |
Shih-Wei Wang |
Taiwan |
| APCMV1099 |
19/11/2024 |
Innovations in Vaccine Research |
Identification of a Novel Antiviral Peptide Via Exploration of Protein Databases and Physicochemical Profiling |
Minhyeong Lee |
Republic of Korea |
| APCMV1107 |
19/11/2024 |
Innovations in Vaccine Research |
Pandemic Preparedness: Understanding Coronavirus Spike-Receptor Interactions and Viral Entry for Improved Therapeutic and Vaccine Developments |
V. Stalin Raj |
India |
| APCMV1143 |
19/11/2024 |
Innovations in Vaccine Research |
Superiority of Gamma-Irradiated Influenza A Vaccine Compared to Seasonal Flu Vaccine in Terms of Humoral Responses and Protective Efficacy |
Mariana Couto Moniz |
Australia |
| APCMV1144 |
19/11/2024 |
Innovations in Vaccine Research |
Superior Immunity of Gamma-Irradiated NDV Vaccine Compared to Formalin-Inactivated Vaccine |
Yimin Chuah |
Australia |
| APCMV1148 |
19/11/2024 |
Innovations in Vaccine Research |
Acute Oral Toxicity Assessment of Recombinant B. Subtilis Spores Expressing Dengue Virus NS1 |
Nurfatihah Zulkifli |
Malaysia |
| APCMV1151 |
19/11/2024 |
Innovations in Vaccine Research |
Recombinant Bacillus Subtilis Spores Expressing SARS-CoV-2 Spike Protein Induced Humoral, Mucosal and Cellular Immunity in Mice |
Nurul Atiqah Nor Hazan |
Malaysia |
| APCMV1174 |
19/11/2024 |
Innovations in Vaccine Research |
Immunogenicity and Protective Efficacy of 3-in-1 Subunit DENV Vaccine in Diet-Induced Obese Mice |
Shu-Wen Wan |
Taiwan |
| APCMV1196 |
19/11/2024 |
Innovations in Vaccine Research |
Targeting Clec9A on Type-I Conventional Dendritic Cells to Induce Broad and Durable Systemic and Mucosal Immune Responses Against SARS-CoV-2 and Sarbecoviruses |
Nicholas Cheang |
Singapore |
| APCMV1199 |
19/11/2024 |
Innovations in Vaccine Research |
Exploiting the Clec9A Targeting Vaccine Platform to Deliver a DENV Subunit Vaccine Candidate |
Geraldine Nadya Putri |
Singapore |
| APCMV1232 |
19/11/2024 |
Innovations in Vaccine Research |
The Role of Bacterial Vaginosis-Associated Bacteria in Trichomonas Vaginalis Adhesion and Pathogenicity in Multi-Species Biofilms |
Shu-Fang Chiu |
Taiwan |
| APCMV1240 |
19/11/2024 |
Innovations in Vaccine Research |
Development of A Novel EV-A71 Monoclonal Antibody for Monitoring Vaccine Potency |
Thi-Hong-Loc Le |
Taiwan |
| APCMV1250 |
19/11/2024 |
Innovations in Vaccine Research |
Deglycosylation of Influenza A H7N9 VLP Enhances Cross-Strain Neutralisation: Unveiling A Promising Vaccine Approach |
Asmaul Husna |
Taiwan |
| APCMV1284 |
19/11/2024 |
Innovations in Vaccine Research |
Predicting Antibody Responses to COVID-19 Vaccines Using Host Factors |
Hsiuyi Chen |
Singapore |
| APCMV1098 |
20/11/2024 |
Host Pathogen Interaction |
Immune Correlates with Disease Severity in Older Patients After SARS-Cov-2 BA.2 Infection in Hong Kong |
Chen Bohao |
Hong Kong SAR |
| APCMV1170 |
20/11/2024 |
Host Pathogen Interaction |
Integrin-Linked Kinase Enhances Enteroviral Infections |
Li-Chiu Wang |
Taiwan |
| APCMV1175 |
20/11/2024 |
Host Pathogen Interaction |
Rab37 Regulates Dengue Virus Attachment by Modulating Viral Entry Receptors on Host Cells |
Wei-Chiao Liao |
Taiwan |
| APCMV1183 |
20/11/2024 |
Host Pathogen Interaction |
The Impacts of the Crosstalk Between Bacterial Vaginosis Associated Bacteria and Trichomonas Vaginalis on the Pathogenesis and Host Immune Responses |
Shu-Fang Chiu |
Taiwan |
| APCMV1214 |
20/11/2024 |
Host Pathogen Interaction |
Impact of Variations Found in Quasispecies on Enterovirus A71 Viral Properties |
Dayna Cheng |
Taiwan |
| APCMV1224 |
20/11/2024 |
Host Pathogen Interaction |
Molecular Characterisation of Dengue Virus Strains from the 2023 Epidemic in Taiwan |
Cheng-Fen Yang |
Taiwan |
| APCMV1234 |
20/11/2024 |
Host Pathogen Interaction |
Identification of Potential Drug Targets of Itaconic Acid Derivatives with a Michael Acceptor Moiety Using Shotgun Proteomics |
Hao-Wei Chu |
Taiwan |
| APCMV1239 |
20/11/2024 |
Host Pathogen Interaction |
Down-Regulation of Serpin D1 (Heparin Cofactor II) Expression by Hepatitis C Virus |
Chee Hing Yang |
Taiwan |
| APCMV1249 |
20/11/2024 |
Host Pathogen Interaction |
Role of 14-3-3 Proteins in the Regulation of Influenza A Virus Replication |
Rei-Lin Kuo |
Taiwan |
| APCMV1254 |
20/11/2024 |
Host Pathogen Interaction |
High Throughput Protein Interaction Screen on Peptide Matrix to Identify Host Factors that Interact with SARS-CoV-2 Proteins |
Amal Rahmeh |
Spain |
| APCMV1285 |
20/11/2024 |
Host Pathogen Interaction |
Investigating the Entry Mechanisms of Human Coronavirus HKU1 Using Human Nasal Organoids |
Julie Chu |
Singapore |
| APCMVE010 |
20/11/2024 |
Host Pathogen Interaction |
Biochemical Simulation of Mutation Synthesis and Repair During SARS-CoV-2 RNA Polymerisation |
Adrian Oo |
USA |
| APCMV1073 |
20/11/2024 |
Pathogenesis and Immunology |
Influenza Virus Infection Instigates a Unique and Pathogenic ER Stress and Unfolded Protein Response in Human Nasal Epithelial Ciliated and Goblet Cells |
Alan Hsu |
Singapore |
| APCMV1103 |
20/11/2024 |
Pathogenesis and Immunology |
Species-Specific Viral Immunity Illuminated by Novel Horseshoe Bat Genomes |
Yue Dong |
China |
| APCMV1121 |
20/11/2024 |
Pathogenesis and Immunology |
Association Of Δ42PD-1 Expression with Increased Regulatory B Cells in Hepatocellular Carcinoma |
Ruomei Gong |
Hong Kong SAR |
| APCMV1181 |
20/11/2024 |
Pathogenesis and Immunology |
SARS-CoV-2 Immune Complexes Signal Through the FcγR Pathway and Activate the NLRP3 Inflammasome |
Stefanie Fung |
Singapore |
| APCMV1187 |
20/11/2024 |
Pathogenesis and Immunology |
Key Amino Acids in the Structural Envelope E Protein Drive the in Vivo Fitness and Virulence of DENV2 Cosmopolitan Strains Via Immune Evasion |
Eunice Tan |
Singapore |
| APCMV1195 |
20/11/2024 |
Pathogenesis and Immunology |
A Comparative Study of the Vaginal Microbiome of Women with Trichomonas Vaginalis, Chlamydia Trachomatis and Neisseria Gonorrhoeae |
Shu-Fang Chiu |
Taiwan |
| APCMV1218 |
20/11/2024 |
Pathogenesis and Immunology |
Determination of Mucosal Immune Response Regions and the Development of Corresponding Assays for the Rapid Determination of Immune Status Against COVID-19 Utilising Saliva Samples |
David Trudil |
United States |
| APCMV1236 |
20/11/2024 |
Pathogenesis and Immunology |
Targeting Neutrophil Myeloperoxidase in Influenza Virus Infection |
Andrew Teo |
Singapore |
| APCMV1243 |
20/11/2024 |
Pathogenesis and Immunology |
Development of a Rapid Assay for the Evaluation of Pathogen-Specific T Cells in Human Samples |
Anthony Tan |
Singapore |
| APCMV1292 |
20/11/2024 |
Pathogenesis and Immunology |
Impact of Viral-Bacterial Co-Detection in Patients with Community-Acquired Pneumonia |
Liang Hui Loo |
Singapore |
| APCMV1047 |
20/11/2024 |
Vector Borne Viruses |
Retrospective Laboratory Determination of Primary Versus Secondary Acute Dengue Infection, Characterisation Between A&E and Inpatient Admissions in a Single Healthcare Tertiary Centre in Singapore |
Wei Yee Wan |
Singapore |
| APCMV1120 |
20/11/2024 |
Vector Borne Viruses |
Evaluation of Yellow Fever Virus Serologic Assays for Diagnosis and Surveillance |
Judith Chui Ching Wong |
Singapore |
| APCMV1184 |
20/11/2024 |
Vector Borne Viruses |
The N153-Linked Glycans on Envelope Protein Protect the Dengue Virus from Antibody-Mediated Clearance |
Donald Heng Rong Ting |
Singapore |
| APCMV1207 |
20/11/2024 |
Vector Borne Viruses |
Unveiling The Agony: Chikungunya Fever Unleashing Severe Arthralgia |
Hui Shan Chua |
Malaysia |
| APCMV1225 |
20/11/2024 |
Vector Borne Viruses |
The Combination of Remdesivir and Ivermectin Exerts Highly Potent and Synergistic Antiviral Activity Against Murine Coronavirus and SARS-CoV-2 Infections |
Ryan Lew |
Singapore |
| APCMV1237 |
20/11/2024 |
Vector Borne Viruses |
Neutrophil Mediators Linked to Tight Junction Disruption and Increased Intestinal Permeability in Severe Dengue |
Andrew Teo |
Singapore |
| APCMV1251 |
20/11/2024 |
Vector Borne Viruses |
Enhanced Production of Severe Fever with Thrombocytopenia Syndrome Virus Glycoprotein Virus-Like Particles Via Low-Temperature Incubation |
Yi-Chin Fan |
Taiwan |
| APCMV1271 |
20/11/2024 |
Vector Borne Viruses |
Screening and Identification of Key Factors for Arbovirus Infection in Mosquito Cells |
Zhanqi Dong |
Singapore |
| APCMV1273 |
20/11/2024 |
Vector Borne Viruses |
Functional Characterisation of O’nyong’nyong Virus-Specific Neutralising Monoclonal Antibodies |
Vanessa Neo |
Singapore |
| APCMV1283 |
20/11/2024 |
Vector Borne Viruses |
Unlocking the Secrets of Mosquito Saliva: Investigating Immune Modulation During Mosquito-Borne Virus Infections |
Siew-Wai Fong |
Singapore |
| APCMVE012 |
20/11/2024 |
Vector Borne Viruses |
Development of Live-Attenuated Vaccines for Chikungunya Virus: A Study on Pathogenicity and Immunogenicity |
Fumiyo Ogawa |
Japan |
| APCMVE013 |
20/11/2024 |
Vector Borne Viruses |
Tetravalent Microprojection-Based Dengue Chimeric Virus Vaccine Raises Potent Neutralising Antibodies in Mice |
Jovin Choo Jia Ying |
Australia |
| APCMV1109 |
20/11/2024 |
Viral Diagnostics |
Comparative Evaluation of Two Commercial Assays- Chromatographic Immunoassay Vs Qualitative Multiplex PCR for Detection of Viral Pathogens in Stool Samples At a Cancer Set Up |
Sujata Lall |
India |
| APCMV1138 |
20/11/2024 |
Viral Diagnostics |
Pre-COVID-19 Paediatric Face-Mask Sampling of Seasonal Respiratory Viruses |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1253 |
20/11/2024 |
Viral Diagnostics |
Diagnosis of Herpes Simplex Virus Infections in the Clinical Laboratory by PCR: An Observational Study Done In Zoram Medical College, Mizoram, India |
Lalrinpari Sailo |
India |
| APCMV1134 |
21/11/2024 |
Blood Borne Viruses |
Galectin-3 Regulates Viral Pathogenesis and Inflammation in H5N1 and H7N9 Avian Influenza Virus Infections |
Zih Syuan Yang |
Taiwan |
| APCMV1135 |
21/11/2024 |
Blood Borne Viruses |
Genetic Insights into HBV S Gene Mutations, Genotypes and Subtypes in HBV-HIV Co-Infected Viz a Viz HBV Mono-Infected Patients: An Observational Study from North India |
Hiba Sami |
India |
| APCMV1182 |
21/11/2024 |
Blood Borne Viruses |
10 Years (2015-2024) of Hepatitis C Drug Resistance Mutations in the Era of Directly Acting Antiviral Therapy |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1266 |
21/11/2024 |
Blood Borne Viruses |
Identification of Novel Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring Solvent-Exposed Region |
Jiang Xiangyi |
China |
| APCMVE009 |
21/11/2024 |
Blood Borne Viruses |
APOBEC3 is the Primary Target of HIV-1 Vif to Produce Infectious Virions in Myeloid Cell Line THP-1 Under Type I Interferon Treatment |
Michael Jonathan |
Japan |
| APCMV1053 |
21/11/2024 |
Other Virus Infections |
Non-Polio Enterovirus Infections in Children and Neonates Presenting to Hospital Requiring Lumbar Puncture In Leicester, United Kingdom 2019-2023: Serotypes And Clinical Characteristics |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1091 |
21/11/2024 |
Other Virus Infections |
Cluster of Acute Parvovirus B19 Cases Dec 2023-May 2024, Leicester, UK – Possible Post-COVID-19 Phenomenon? |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1202 |
21/11/2024 |
Other Virus Infections |
Improving Prognosis Through Early Diagnosis: Neonatal Herpetic Keratoconjunctivitis |
Hui Shan Chua |
Malaysia |
| APCMV1203 |
21/11/2024 |
Other Virus Infections |
Identifying Gaps in Congenital CMV Detection at A Single Site, Tertiary Hospital, Leicester UK |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1260 |
21/11/2024 |
Other Virus Infections |
Concurrent Cytomegalovirus Retinitis and Neurosyphilis Both Presenting as Bilateral Optic Neuritis in a Patient with HIV: A Case Report |
Rafshanjani Adil |
Philippines |
| APCMV1010 |
21/11/2024 |
Prevention and Control of Viral Infections |
Clinical Analysis of Reinfection/Newly Infected HCV Infection in Long-Term Treatment of HIV/AIDS Patients |
Yun He |
China |
| APCMV1011 |
21/11/2024 |
Prevention and Control of Viral Infections |
Tanomastat Exerts Multi-Targeted Inhibitory Effects on Viral Capsid Dissociation and RNA Replication in Human Enteroviruses |
Therese Lim |
Singapore |
| APCMV1042 |
21/11/2024 |
Prevention and Control of Viral Infections |
WW Domain-Containing Oxidoreductase Functions as A Novel IRES Trans-Acting Factor for Suppressing Enterovirus A71 Initial Translation in Host Cells |
Wei Chiang |
Taiwan |
| APCMV1046 |
21/11/2024 |
Prevention and Control of Viral Infections |
Mitochondrial Uncouplers as A Broad-Spectrum Antiviral Agent |
Kunlakanya Jitobaom |
Thailand |
| APCMV1080 |
21/11/2024 |
Prevention and Control of Viral Infections |
Novel Antiviral Strategies: Veratides and Antibody Fusions Overcome Therapeutic Challenges and Improve Efficacy |
Hyunjin Jeon |
Republic of Korea |
| APCMV1082 |
21/11/2024 |
Prevention and Control of Viral Infections |
Repeated Exposure to SARS-CoV-2 Antigens Induces Exceptionally Broad and Potent Neutralising Immunity to Major Sarbecoviruses in Humans Including SARS-CoV-1 |
Peng Chen |
China |
| APCMV1141 |
21/11/2024 |
Prevention and Control of Viral Infections |
Synergistic Antiviral Effect of Positively Surface-Charged Silver Nanoparticles with Oseltamivir Against Influenza a Viruses at Biocompatible Dosage |
Ping Cheng Liu |
Taiwan |
| APCMV1186 |
21/11/2024 |
Prevention and Control of Viral Infections |
Unveiling MARVAS213: A Novel Antiviral for Enterovirus RNA Replication Discovered Via Protein Interaction Screening |
Yuhui Deborah Fong |
Singapore |
| APCMV1188 |
21/11/2024 |
Prevention and Control of Viral Infections |
Deciphering Enterovirus D68 Antiviral Mechanisms |
Khoo Xuan Wei |
Singapore |
| APCMV1209 |
21/11/2024 |
Prevention and Control of Viral Infections |
CRISPR/Cas9-Generated CTL16 Knockout in Aedes Aegypti Reveals Impact on DENV Replication and IMD And JAK/STAT Immune Signalling |
Wei-Liang Liu |
Taiwan |
| APCMV1212 |
21/11/2024 |
Prevention and Control of Viral Infections |
Role of the Structural Region P1 in Enterovirus-A71 Fitness and Virulence |
Kai Hui Clarissa Tan |
Singapore |
| APCMV1226 |
21/11/2024 |
Prevention and Control of Viral Infections |
Study on the Seroepidemiology of Japanese Encephalitis in Tainan, Taiwan |
Ya Fang Wang |
Taiwan |
| APCMV1272 |
21/11/2024 |
Prevention and Control of Viral Infections |
Targeting Chemokine Receptors with the ML/AI Web Service GPCRVS for GPCR Virtual Screening |
Dorota Latek |
Poland |
| APCMV1048 |
21/11/2024 |
Prevention and Control of Viral Infections |
Therapeutic Potential of an Anti-Gn Glycoprotein Antibody Against Severe Fever with Thrombocytopenia Syndrome Virus Infection in A129 Mice |
Jinah Lee |
Republic of Korea |
| APCMV1019 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Increased Prevalence of Human Astrovirus Type 1 Infection in the Summer of 2022: An 8-Year Analysis |
Hyun Soo Kim |
Republic of Korea |
| APCMV1030 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Integrated Approach for Real-Time Detection and Mitigation of Airborne Coronaviruses in Indoor Environments |
Katheresan Selvam Sooriya Kannan |
Singapore |
| APCMV1076 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Low False-Recent Rate of the HIV-1 Rapid Test for Recent Infection in Detecting Long-Standing HIV Infection |
Supaporn Suparak |
Thailand |
| APCMV1146 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Molecular Analysis of Mpox Genomes from Patients in Central Thailand Suggests the Circulation of Multiple Sub-Lineages, 2023 |
Spencer Sterling |
Thailand |
| APCMV1152 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
The Disease Risks and Vaccine Gaps of Known Betacoronaviruses and Henipaviruses |
Beng Lee Lim |
Singapore |
| APCMV1162 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
SARS-CoV-2 Variants Genetic Profile Under Immune Selection in Healthy and Immunocompromised Individuals in Vitro |
Jolene Fu |
Malaysia |
| APCMV1173 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Novel Intertypic Recombinant Coxsackievirus A2 with Specific Amino Acid Mutations in the RNA-Dependent RNA Polymerase Potentially Associated with Its Emergence |
Zhenfeng Xie |
Thailand |
| APCMV1180 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Association of COVID-19 with Short- and Long-Term Risk of Cardiovascular Disease and Mortality: A Prospective Cohort in UK Biobank |
Sukriti Mathur |
Singapore |
| APCMV1192 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Factors Affecting Differences in East-West Pandemic Responses |
Julian Wei-Tze Tang |
United Kingdom |
| APCMV1257 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Post-Pandemic Enterovirus Epidemiology and Evolution in Northern Taiwan |
Lin Ya-Jhu |
Taiwan |
| APCMV1258 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
COVID-19 Molecular Surveillance in Taiwan |
Tzu-Hsuan Hsieh |
Taiwan |
| APCMV1264 |
21/11/2024 |
Virus Surveillance and Public Health Intervention |
Investigating the Evolution of Seasonal Human Coronaviruses and Their Application to Future Evolutionary Directions of SARS-CoV-2 |
Hannah Goldswain |
United Kingdom |
